Trials / Withdrawn
WithdrawnNCT00571779
AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB
Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolations Using the AtriCure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- AtriCure, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility study arm to evaluate the safety of adding the left atrial linear connecting lesions of the Cox-Maze lesion set to the current RESTORE SR II IDE study procedure of performing pulmonary vein isolation, selected left atrial autonomic ganglionated plexi (GP) ablation, and optional left atrial appendage (LAA) excision/exclusion on a beating heart for patients with permanent or persistent Atrial Fibrillation (AF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AtriCure Bipolar System |
Timeline
- First posted
- 2007-12-12
- Last updated
- 2011-02-21
Source: ClinicalTrials.gov record NCT00571779. Inclusion in this directory is not an endorsement.